Statements of Stockholders' Equity - USD ($)
|
Series A and Z Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total |
Beginning balance, shares at Dec. 31, 2016 |
115,894
|
0
|
|
|
|
|
Beginning balance, amount at Dec. 31, 2016 |
$ 116
|
$ 0
|
$ 4,703,848
|
$ (1,872,908)
|
$ 0
|
$ 2,831,056
|
Conversion of preferred stock to common stock, shares |
(115,894)
|
8,335,080
|
|
|
|
|
Conversion of preferred stock to common stock, amount |
$ (116)
|
$ 8,335
|
(8,219)
|
|
|
0
|
Issuance of common stock at $6 per share for cash, net of $32,400 issuance costs, shares |
|
789,674
|
|
|
|
|
Issuance of common stock at $6 per share for cash, net of $32,400 issuance costs, amount |
|
$ 790
|
4,704,856
|
|
|
4,705,646
|
Tactic Pharma shares surrendered, shares |
|
(2,888,727)
|
|
|
|
|
Tactic Pharma shares surrendered, amount |
|
$ (2,889)
|
2,889
|
|
|
0
|
Shares issued in Gem transaction, net of issuance costs of $169,257, shares |
|
3,055,394
|
|
|
|
|
Shares issued in Gem transaction, net of issuance costs of $169,257, amount |
|
$ 3,055
|
18,329,310
|
|
|
18,332,365
|
Non-cash stock compensation |
|
|
305,205
|
|
|
305,205
|
Net loss |
|
|
|
(16,554,872)
|
|
(16,554,872)
|
Ending balance, shares at Dec. 31, 2017 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Dec. 31, 2017 |
$ 0
|
$ 9,291
|
28,037,889
|
(18,427,780)
|
0
|
9,619,400
|
Non-cash stock compensation |
|
|
114,526
|
|
|
114,526
|
Net loss |
|
|
|
(876,347)
|
|
(876,347)
|
Ending balance, shares at Mar. 31, 2018 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Mar. 31, 2018 |
$ 0
|
$ 9,291
|
28,152,415
|
(19,304,127)
|
0
|
8,857,579
|
Beginning balance, shares at Dec. 31, 2017 |
0
|
9,291,421
|
|
|
|
|
Beginning balance, amount at Dec. 31, 2017 |
$ 0
|
$ 9,291
|
28,037,889
|
(18,427,780)
|
0
|
9,619,400
|
Non-cash stock compensation |
|
|
|
|
|
296,340
|
Net loss |
|
|
|
|
|
(2,337,471)
|
Ending balance, shares at Sep. 30, 2018 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Sep. 30, 2018 |
$ 0
|
$ 9,291
|
28,334,229
|
(20,765,251)
|
(2,385)
|
7,575,884
|
Beginning balance, shares at Dec. 31, 2017 |
0
|
9,291,421
|
|
|
|
|
Beginning balance, amount at Dec. 31, 2017 |
$ 0
|
$ 9,291
|
28,037,889
|
(18,427,780)
|
0
|
9,619,400
|
Shares issued in Gem transaction, net of issuance costs of $169,257, amount |
|
|
|
|
|
0
|
Non-cash stock compensation |
|
|
529,332
|
|
|
529,332
|
Net loss |
|
|
|
(3,227,932)
|
|
(3,227,932)
|
Other comprehensive gain (loss) |
|
|
|
|
(2,396)
|
(2,396)
|
Ending balance, shares at Dec. 31, 2018 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Dec. 31, 2018 |
$ 0
|
$ 9,291
|
28,567,221
|
(21,655,712)
|
(2,396)
|
6,918,404
|
Beginning balance, shares at Mar. 31, 2018 |
0
|
9,291,421
|
|
|
|
|
Beginning balance, amount at Mar. 31, 2018 |
$ 0
|
$ 9,291
|
28,152,415
|
(19,304,127)
|
0
|
8,857,579
|
Non-cash stock compensation |
|
|
88,570
|
|
|
88,570
|
Net loss |
|
|
|
(640,184)
|
|
(640,184)
|
Other comprehensive gain (loss) |
|
|
|
|
(1,579)
|
(1,579)
|
Ending balance, shares at Jun. 30, 2018 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Jun. 30, 2018 |
$ 0
|
$ 9,291
|
28,240,985
|
(20,125,067)
|
(1,579)
|
8,123,630
|
Non-cash stock compensation |
|
|
93,244
|
|
|
93,244
|
Net loss |
|
|
|
(640,184)
|
|
(640,184)
|
Other comprehensive gain (loss) |
|
|
|
|
(806)
|
(806)
|
Ending balance, shares at Sep. 30, 2018 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Sep. 30, 2018 |
$ 0
|
$ 9,291
|
28,334,229
|
(20,765,251)
|
(2,385)
|
7,575,884
|
Non-cash stock compensation |
|
|
232,992
|
|
|
232,992
|
Net loss |
|
|
|
(890,461)
|
|
(890,461)
|
Other comprehensive gain (loss) |
|
|
|
|
(11)
|
(11)
|
Ending balance, shares at Dec. 31, 2018 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Dec. 31, 2018 |
$ 0
|
$ 9,291
|
28,567,221
|
(21,655,712)
|
(2,396)
|
6,918,404
|
Non-cash stock compensation |
|
|
233,776
|
|
|
233,776
|
Net loss |
|
|
|
(1,376,235)
|
|
(1,376,235)
|
Other comprehensive gain (loss) |
|
|
|
|
(2,127)
|
(2,127)
|
Ending balance, shares at Mar. 31, 2019 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Mar. 31, 2019 |
$ 0
|
$ 9,291
|
28,800,997
|
(23,031,947)
|
(4,523)
|
5,773,818
|
Beginning balance, shares at Dec. 31, 2018 |
0
|
9,291,421
|
|
|
|
|
Beginning balance, amount at Dec. 31, 2018 |
$ 0
|
$ 9,291
|
28,567,221
|
(21,655,712)
|
(2,396)
|
6,918,404
|
Non-cash stock compensation |
|
|
|
|
|
734,365
|
Net loss |
|
|
|
|
|
(3,018,015)
|
Ending balance, shares at Sep. 30, 2019 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Sep. 30, 2019 |
$ 0
|
$ 9,291
|
29,301,586
|
(24,673,727)
|
(12,195)
|
4,624,955
|
Beginning balance, shares at Mar. 31, 2019 |
0
|
9,291,421
|
|
|
|
|
Beginning balance, amount at Mar. 31, 2019 |
$ 0
|
$ 9,291
|
28,800,997
|
(23,031,947)
|
(4,523)
|
5,773,818
|
Non-cash stock compensation |
|
|
257,633
|
|
|
257,633
|
Net loss |
|
|
|
(905,700)
|
|
(905,700)
|
Other comprehensive gain (loss) |
|
|
|
|
1,067
|
1,067
|
Ending balance, shares at Jun. 30, 2019 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Jun. 30, 2019 |
$ 0
|
$ 9,291
|
29,058,630
|
(23,937,647)
|
(3,456)
|
5,126,818
|
Non-cash stock compensation |
|
|
242,956
|
|
|
242,956
|
Net loss |
|
|
|
(736,080)
|
|
(736,080)
|
Other comprehensive gain (loss) |
|
|
|
|
(8,739)
|
(8,739)
|
Ending balance, shares at Sep. 30, 2019 |
0
|
9,291,421
|
|
|
|
|
Ending balance, amount at Sep. 30, 2019 |
$ 0
|
$ 9,291
|
$ 29,301,586
|
$ (24,673,727)
|
$ (12,195)
|
$ 4,624,955
|